Related references
Note: Only part of the references are listed.Breast cancer survival in NordicBRCA2mutation carriers-unconventional association with oestrogen receptor status
Elinborg J. Olafsdottir et al.
BRITISH JOURNAL OF CANCER (2020)
Oestrogen receptor status and survival in women with BRCA2-associated breast cancer
Kelly Metcalfe et al.
BRITISH JOURNAL OF CANCER (2019)
Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis
Harindra Jayasekara et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The spectrum of mutations predisposing to familial breast cancer in Poland
Cezary Cybulski et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
P. A. Francis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Predictors of survival for breast cancer patients with a BRCA1 mutation
Steven A. Narod et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
Jon G. Jonasson et al.
BRITISH JOURNAL OF CANCER (2016)
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Kelly Metcalfe et al.
JAMA ONCOLOGY (2015)
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
Kelly Metcalfe et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Breast Cancer Prognosis in BRCA1 and BRCA2 Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
Tomasz Byrski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays
Anita L. Bane et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource
GJ Mann et al.
BREAST CANCER RESEARCH (2006)
Agreement between self-reported breast cancer treatment and medical records in a population-based breast cancer family registry
KA Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort
KA Phillips et al.
FAMILIAL CANCER (2005)
Estrogen receptor status in BRCA1- and BRCA2-related breast cancer:: The influence of age, grade, and histological type
WD Foulkes et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
